Literature DB >> 32852231

Comparison between outcomes of endovascular and surgical treatments of ruptured anterior communicating artery aneurysms.

Lauren Harris1, Ciaran Scott Hill1, Matthew Elliot1, Teresa Fitzpatrick1, Anthony Ghosh1, Raghu Vindlacheruvu1.   

Abstract

INTRODUCTION: The natural history and optimal treatment of previously ruptured anterior communicating artery (ACOM) aneurysms that recur is unknown. This study looks at rates of complications and recurrences of ruptured ACOM aneurysms treated endovascularly and surgically.
MATERIALS AND METHODS: A retrospective observational study of all patients presenting to a single tertiary neurosurgical centre with the first presentation of subarachnoid haemorrhage (SAH) secondary to a ruptured ACOM aneurysm. Data was collected from November 2012 to September 2018 and included baseline demographics, aneurysm characteristics, management, complications, follow-up imaging, and clinical outcomes.
RESULTS: 137 patients were included in the study. 113 aneurysms were coiled and 19 were clipped. Management decisions were taken by the multidisciplinary team based on aneurysm morphology or the presence of a haematoma exerting mass effect. There were 187.5 patient-years of follow-up, with a median of 3 years (range 0-73 months). Rates of vasospasm, infarction, CSF diversion, rebleed, length of stay, and functional outcome were not significantly different in the two cohorts. There was a statistically significant increase in the risk of ACOM recurrence in the coiled group when compared to the clipped group at one year (p = .0433). 15 patients required further treatment at a median time of 16 months. In a subgroup group analysis of coiled aneurysms, there was no statistical differences in rates of rebleeding or the functional outcome in those that had aneurysm recurrence and those that did not.
CONCLUSIONS: This study suggests patients with aneurysms treated by endovascular coiling have an increased risk of recurrence versus those treated with clipping. However, the risk of rebleed was not statistically significant. The prevention and impact of recurrence and residual aneurysms remains incompletely understood. Hence, treatment decisions should be taken by patients after they have been given carefully considered recommendations from the multi-disciplinary team.

Entities:  

Keywords:  Anterior communicating artery (ACOM) aneurysm; clipping; endovascular coiling; recurrence; surgery

Mesh:

Year:  2020        PMID: 32852231     DOI: 10.1080/02688697.2020.1812517

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  5 in total

Review 1.  Intra-procedural complications, success rate, and need for retreatment of endovascular treatments in anterior communicating artery aneurysms: a systematic review and meta-analysis.

Authors:  Pourya Yarahmadi; Ali Kabiri; Amirmohammad Bavandipour; Pascal Jabbour; Omid Yousefi
Journal:  Neurosurg Rev       Date:  2022-08-27       Impact factor: 2.800

Review 2.  Economic and Humanistic Burden of Cerebral Vasospasm and Its Related Complications after Aneurysmal Subarachnoid Hemorrhage: A Systematic Literature Review.

Authors:  Juliette C Thompson; François-Xavier Chalet; Eric J Manalastas; Neil Hawkins; Grammati Sarri; Darren A Talbot
Journal:  Neurol Ther       Date:  2022-04-20

3.  Risk Factors for Recurrence of Intracranial Aneurysm After Coil Embolization: A Meta-Analysis.

Authors:  Ji Jin; Geng Guo; Yeqing Ren; Biao Yang; Yongqiang Wu; Shule Wang; Yanqi Sun; Xiaogang Wang; Yuxiao Wang; Jianzhong Zheng
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

4.  Outcome of ruptured anterior communicating artery aneurysm treatment compared between surgical clipping and endovascular coiling: A single-center analysis.

Authors:  Sang Houn Lee; Jung Soo Park
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

5.  Plasma Amino Acids May Improve Prediction Accuracy of Cerebral Vasospasm after Aneurysmal Subarachnoid Haemorrhage.

Authors:  Ernest Jan Bobeff; Malgorzata Bukowiecka-Matusiak; Konrad Stawiski; Karol Wiśniewski; Izabela Burzynska-Pedziwiatr; Magdalena Kordzińska; Konrad Kowalski; Przemyslaw Sendys; Michał Piotrowski; Dorota Szczesna; Ludomir Stefańczyk; Lucyna Alicja Wozniak; Dariusz Jan Jaskólski
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.